ClinicalTrials.gg
Not yet recruitingNCT07683286Updated Jul 6, 2026

Pilates Exercises Versus Intermittent Fasting Diet on Physical and Metabolic Aging Process in Obese Perimenopausal Women

An interventional study of Pilates exercise and Intermittent Fasting Diet in Obesity, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to female participants aged 40 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-06.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
40 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Obesity by Cairo University — 15 open to participants now, 18 under way, none of them phase 3. Obesity · Cairo University.

Planned enrollment
28th of 47
50 · median 60
Started
2026
with 10 others
No phase
46 of 54
13 open now
Primary completion
2027-01
later than 14 of 17 live
Registered
52nd of 54
by date

Among the 54 studies in Obesity by Cairo University, this one is the 28th largest by planned enrollment of the 47 interventional ones that give a count, is one of 11 that started in 2026, is one of 46 with no phase, reaches primary completion later than 14 of the 17 other live ones, and was the 52nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

15 of the 54 studies in Obesity by Cairo University are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 15 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 40 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Obesity by Cairo University, or all of them as a file.
02

Study summary

This study aims to compare the effect of pilates exercises versus intermittent fasting diet on physical and metabolic aging parameters in obese perimenopausal women.

Read the detailed description

Obesity is associated with a shorter life expectancy, partly due to its role in accelerating the aging process. The conditions and comorbidities linked to obesity mirror those of age-related diseases. Individuals with obesity are at a higher risk for various age-related conditions, including cardiovascular disease (CVD), hypertension, type 2 diabetes mellitus (T2DM), and cance.

Aging is a natural part of the human life cycle, characterized by a gradual loss of physiological integrity, leading to functional decline and increased vulnerability to mortality. Alongside the onset of age-related diseases in older adults, common aging phenotypes, such as redox imbalance, mitochondrial dysfunction, increased apoptosis, cellular senescence, insufficient autophagy, and chronic inflammation, are observed in both humans and animals. Similar mechanisms underpin the onset of age-related diseases in obesity and excessive calorie intake, suggesting that obesity accelerates aging through these interconnected pathways.

Pilates has gained popularity as a holistic exercise approach that emphasizes respiration, body control, and movement precision. Current research supports the positive effects of Pilates on respiratory muscle strength, balance, overall physical performance, and quality of life. Additionally, a recent systematic review and meta-analysis concluded that Pilates is an effective alternative for improving maximal oxygen uptake (VO2max) values.

Fasting, which involves abstaining from food for extended periods ranging from hours to days, triggers significant metabolic changes referred to as the 'metabolic switch'. One of the most important metabolic shifts during fasting is the increased production of ketone bodies, such as acetoacetic acid, β-hydroxybutyric acid (β-HB), and acetone, in the liver.

Given the heightened vulnerability of obese perimenopausal women to accelerated aging processes and metabolic dysfunction, there is a critical need to identify the most effective lifestyle interventions for this high-risk population. While both Pilates exercise and intermittent fasting show promise in addressing aging-related parameters through different mechanisms, no direct comparative studies have evaluated their relative efficacy on comprehensive physical and metabolic aging markers in obese perimenopausal women.

03

Conditions studied

  • Obesity

Browse trials for

04

Who can participate

Ages eligible
40 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Their will be ranged from 30 to 35 kg/m2.
  • Waist hip ratio will be > 1.
  • Total cholesterol (TC) will be > 200 mg/dl.
  • Triglycerides (TG) will be > 150 mg/dl.
  • Low-density lipoprotein (LDL) will be > 100 mg/dl.
  • High-density lipoprotein (HDL) will be \< 40 mg/dl.

Exclusion criteria

Exclusion Criteria:

  • Diabetes type I.
  • Concomitant cardiac disorders.
  • Pregnant or breastfeeding.
  • Eating disorders as Anorexia.
  • Thyroid disorders.
  • Kidney disorders.
  • Severe joint issues as arthritis and post-joint replacement.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Pilates exercise group

    The participants will be treated with Pilates exercises, 4 times per week, 60 minutes per session, for 12 weeks.

    Other: Pilates exercise

  • Experimental
    Intermittent Fasting Diet

    The participants will follow intermittent fasting diet for 12 weeks.

    Other: Intermittent Fasting Diet

Interventions

  • OtherPilates exercise

    Each exercise will be ranged from 1 to 3 minutes, with a break of 10 seconds. The exercises include: Flat Abs: Pilates Hundred; Flat Abs: Roll-Up; Obliques: Twist and Reach; Lower Back: Shoulder Bridge; Lower Body: Kneeling Side Kicks; Lower Body: Leg Swings; Stamina: Wall Chair.

  • OtherIntermittent Fasting Diet

    This fasting regimen involves fasting for 16 hours each day and limiting eating to an 8-hour window. The 16:8 intermittent fasting protocol is relatively straightforward. It divides the day into two main periods: the fasting period which is 16 hours and the 8 hours eating window .

06

What researchers measure

Primary outcomes

  1. Body weight

    Weight will be measured in kilograms by weight-height scale for all participants before and after treatment program.

    Time frame: 12 weeks

  2. Body mass index

    It will be measured by weight-height scale by dividing body weight in kilograms by height meter square.

    Time frame: 12 weeks

  3. Waist circumference

    The waist circumference will be measured in centimeters at the narrowest point between xipho-sternum and the iliac crest at the end of a gentle expiration.

    Time frame: 12 weeks

  4. Hip circumference

    Hip circumference will be measured in centimeters at the maximum circumference at the level of the femoral trochanter.

    Time frame: 12 weeks

  5. Waist-hip ratio

    It will be calculated by dividing waist circumference by hip circumference for all participants before and after treatment.

    Time frame: 12 weeks

  6. Resting Heart Rate Measurement

    Resting heart rate (RHR) is the number of heartbeats per minute (bpm) when a person is at complete rest. It is a simple indicator of cardiovascular health. it will be measured by pulse oximeter. Normal Range: Adults: 60-100 bpm

    Time frame: 12 weeks

  7. Maximum Heart Rate

    It will be calculated through equation: 220- age

    Time frame: 12 weeks

  8. Maximum oxygen consumption (VO2 max)

    It will be calculated through the equation:VO2 max = 15.3 x (maximum heart rate / resting heart rate).

    Time frame: 12 weeks

Secondary outcomes

  1. Assessment of the health-related quality of life

    It will be assessed using the short form (SF-36) questionnaire, which consists of 36 questions. Answers will be awarded a score on a five-point scale (0-4). The 36-question SF-36 evaluates eight health domains: physical functioning (10 questions), physical role limits (4 questions), bodily pain (2 questions), general health perceptions (5 questions), energy/vitality (4 questions), social function (2 questions), emotional role limits (3 questions), and mental health (5 questions). The scores will be transformed to range from 0 for the worst health to 100 for the ideal health.

    Time frame: 12 weeks

  2. Total cholesterol (TC)

    Total cholesterol (TC) is the total concentration of cholesterol in the blood. Normal range: \<200 mg/dL (\<5.2 mmol/L)

    Time frame: 12 weeks

  3. Triglycerides

    Triglycerides (TG) are the primary form of fat stored in the body and circulate in the blood as an important source of energy. Elevated triglyceride levels are associated with an increased risk of cardiovascular disease. Normal: \<150 mg/dL (\<1.7 mmol/L)

    Time frame: Normal: <150 mg/dL (<1.7 mmol/L)

  4. High-density lipoprotein

    High-density lipoprotein is commonly referred to as "good cholesterol" because it transports excess cholesterol from peripheral tissues to the liver for excretion, thereby reducing cardiovascular risk. Normal range for women: \<50 mg/dL (\<1.3 mmol/L)

    Time frame: 12 weeks

  5. Low-density lipoprotein

    Low-density lipoprotein is often called "bad cholesterol," transports cholesterol from the liver to peripheral tissues. Elevated LDL-C is a major risk factor for atherosclerosis and cardiovascular disease. Normal: \<100 mg/dL (\<2.6 mmol/L)

    Time frame: 12 weeks

  6. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

    It is a widely used index for estimating insulin resistance based on fasting plasma glucose and fasting serum insulin concentrations. It is commonly used in clinical research to assess insulin sensitivity. Normal insulin sensitivity: \<2.0

    Time frame: 12 weeks

07

Study locations

1 site
  • Hadeel Adil Mohamed
    Al Fayyum, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 6 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2026
First posted
Jul 6, 2026
StartEst.
Jul 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 16, 2027
Last update
Jul 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07683286
Lead sponsor
Cairo University
Responsible party
Hadeel Adil Mohammed (Principal investigator, Cairo University) — Principal investigator
First posted
Jul 6, 2026
Start date
Jul 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 16, 2027 (estimated)
Last update
Jul 6, 2026

Study contacts

Hadeel Mohammed, Master
Contact
hadeltv@yahoo.com
01065489193
Mohamed Abo Eleinien, PHD
Contact
Drfawzygyna61@gmail.com
01001414404
Doaa Osman, As Professor
study director · Cairo University
Mohamed Awad, Professor
study chair · Cairo University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion